Modulation of CD8+ T cell avidity by increasing the turnover of viral antigen during infection

Cellular Immunology

Volumn 231, Issue 1-2, 2004, Pages 14-19

  Gray, Peter M ^a,b   Parks, Griffith D ^a   Alexander Miller, Martha A ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Avidity; CTL; Paramyxovirus; Respiratory tract; Virus

Indexed keywords

CD8 ANTIGEN; GLYCINE CLEAVAGE SYSTEM; UBIQUITIN; VIRUS ANTIGEN; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; MOUSE; NONHUMAN; PARAMYXOVIRUS; PRIORITY JOURNAL; RNA VIRUS INFECTION; T LYMPHOCYTE;

ANIMALS; ANTIGENS, VIRAL; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; HALF-LIFE; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; PHOSPHOPROTEINS; PROTEIN BINDING; RUBULAVIRUS INFECTIONS; SIMIAN VIRUS 5; UBIQUITIN; VIRAL PROTEINS;

PARAMYXOVIRIDAE;

EID: 20144366327     PISSN: 00088749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cellimm.2004.12.002     Document Type: Article

References (24)

1. M.A. Alexander-Miller, G.R. Leggatt, and J.A. Berzofsky Selective expansion of high- or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy Proc. Natl. Acad. Sci. USA 93 1996 4102 4107
2. M. Derby, M. Alexander-Miller, R. Tse, and J. Berzofsky High-avidity CTL exploit two complementary mechanisms to provide better protection against viral infection than low-avidity CTL J. Immunol. 166 2001 1690 1697
3. A. Gallimore, T. Dumrese, H. Hengartner, R.M. Zinkernagel, and H.G. Rammensee Protective immunity does not correlate with the hierarchy of virus-specific cytotoxic T cell responses to naturally processed peptides J. Exp. Med. 187 1998 1647 1657
4. C. Sedlik, G. Dadaglio, M.F. Saron, E. Deriaud, M. Rojas, S.I. Casal, and C. Leclerc In vivo induction of a high-avidity, high-frequency cytotoxic T-lymphocyte response is associated with antiviral protective immunity J. Virol. 74 2000 5769 5775
5. H.J. Zeh III, D. Perry-Lalley, M.E. Dudley, S.A. Rosenberg, and J.C. Yang High avidity CTLs for two self-antigens demonstrate superior in vitro and in vivo antitumor efficacy J. Immunol. 162 1999 989 994
6. C. Yee, P.A. Savage, P.P. Lee, M.M. Davis, and P.D. Greenberg Isolation of high avidity melanoma-reactive CTL from heterogeneous populations using peptide-MHC tetramers J. Immunol. 162 1999 2227 2234
7. S. Chakrabarti, K. Brechling, and B. Moss Vaccinia virus expression vector: coexpression of beta-galactosidase provides visual screening of recombinant virus plaques Mol. Cell. Biol. 5 1985 3403 3409
8. P.M. Gray, G.D. Parks, and M.A. Alexander-Miller A novel CD8-independent high-avidity cytotoxic T-lymphocyte response directed against an epitope in the phosphoprotein of the paramyxovirus simian virus 5 J. Virol. 75 2001 10065 10072
9. M.A. Alexander-Miller Differential expansion and survival of high and low avidity cytotoxic T cell populations during the immune response to a viral infection Cell. Immunol. 201 2000 58 62
10. + T cells are the initial population elicited following viral infection of the respiratory tract J. Immunol. 170 2003 174 181
11. N. Tarbouriech, J. Curran, R.W. Ruigrok, and W.P. Burmeister Tetrameric coiled coil domain of Sendai virus phosphoprotein Nat. Struct. Biol. 7 2000 777 781
12. F. Rodriguez, J. Zhang, and J.L. Whitton DNA immunization: ubiquitination of a viral protein enhances cytotoxic T-lymphocyte induction and antiviral protection but abrogates antibody induction J. Virol. 71 1997 8497 8503
13. T. Tobery, and R.F. Siliciano Cutting edge: induction of enhanced CTL-dependent protective immunity in vivo by N-end rule targeting of a model tumor antigen J. Immunol. 162 1999 639 642
14. + T cell recognition J. Biol. Chem. 276 2001 33353 33360
15. C.M. Pickart Back to the future with ubiquitin Cell 116 2004 181 190
16. + T cells without selection of higher affinity TCR Nat. Immunol. 2 2001 711 717
17. d-restricted cytotoxic T lymphocytes J. Exp. Med. 173 1991 849 858
18. D.E. Speiser, D. Kyburz, U. Stubi, H. Hengartner, and R.M. Zinkernagel Discrepancy between in vitro measurable and in vivo virus neutralizing cytotoxic T cell reactivities. Low T cell receptor specificity and avidity sufficient for in vitro proliferation or cytotoxicity to peptide-coated target cells but not for in vivo protection J. Immunol. 149 1992 972 980
19. A.G. Cawthon, H. Lu, and M.A. Alexander-Miller Peptide requirement for CTL activation reflects the sensitivity to CD3 engagement: correlation with CD8αβ versus CD8αα expression J. Immunol. 167 2001 2577 2584
20. + T cells J. Immunol. 170 2003 1822 1829
21. G.D. Parks, K.R. Ward, and J.C. Rassa Increased readthrough transcription across the simian virus 5 M-F gene junction leads to growth defects and a global inhibition of viral mRNA synthesis J. Virol. 75 2001 2213 2223
22. G.W. Wertz, V.P. Perepelitsa, and L.A. Ball Gene rearrangement attenuates expression and lethality of a nonsegmented negative strand RNA virus Proc. Natl. Acad. Sci. USA 95 1998 3501 3506
23. J. Shim, and M. Karin The control of mRNA stability in response to extracellular stimuli Mol. Cell 14 2002 323 331
24. M. Rechsteiner, and S.W. Rogers PEST sequences and regulation by proteolysis Trends Biochem. Sci. 21 1996 267 271